Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-21-018310

Director sold 11,813 shares at $55.10 ($650,896)

  • Director acquired 10,353 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KROLL MARK W · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-26 Exercise or conversion : show line 1 in the form +10,353 $35.50 $367,557 30,253 D
2021-05-26 Sale : show line 2 in the form −11,813 $55.10 $650,896 18,440 D
Open-market sales · 11,813 sh · avg $55.10 · $650,896

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-26 Exercise or conversion : show line 3 in the form Non-qualified Stock Option (Right to Buy) −10,353 0 D
Loading xslF345X03/form4.xml…